Although preprandial dosing of RAI is considered to be the standard practice, postprandial administration of insulin glulisine has also been advocated by Mitri and colleagues [15], focusing on the potential benefit of postmeal administration of short-acting insulins for the weight management of type 2 diabetes. Here, INS is linked to type 2 diabetes mellitus.